Medically Written & Reviewed By Dr. Ajit Kumar, MD (Medicine) — Founder, Medimadad. About the Author | Editorial Policy Two of the most prescribed weight loss drugs in the world – Ozempic (semaglutide) and Mounjaro (tirzepatide) – are now being scrutinised for a side effect that doctors rarely mention in the consultation room: significant muscle […]
26 Articles
Breaking health research, new drug approvals, landmark clinical trials, and emerging science — summarised clearly for informed readers. Updated as major findings are published.
Survodutide’s phase 3 results are in. Here is how its real weight-loss and fatty liver (MASLD) data compare to Ozempic and Zepbound — and what is still unapproved, including in India.
